May 23, 2013 3:25 AM ET

Pharmaceuticals

Company Overview of Celentyx Ltd.

Company Overview

Celentyx Ltd., a pharmaceutical company, develops treatments for diseases of the human immune system. Its solutions include Immuno-Profiling platform, which enables identification of targets with therapeutic potential and rapid analysis of drug action on human immune cells; and Novel Clinical Indication Profiling, which applies the Immuno-Profiling platform to develop reprofiled drug candidates for diseases of the human immune system. The company’s products also include CX1001, a therapy for B-cell cancers. In addition, its services include rapid analysis/screening of drug action on physiological and pathological human immune tissues and cells; and rapid analysis of drug action on human immu...

Detailed Description

Birmingham Research Park

Vincent Drive

Edgbaston

Birmingham,  B15 2SQ

United Kingdom

Founded in 2004

Phone:

44 12 1414 8199

Fax:

44 12 1414 4509

www.celentyx.com

Key Executives for Celentyx Ltd.

Co-Founder
Co-Founder
Investor Director and Director
Compensation as of Fiscal Year 2012.

Similar Private Companies By Industry

Company Name Region
Point-2-Point Genomics Ltd. Europe
Janssen-Cilag Limited Europe
GlaxoSmithKline Capital plc Europe
Novartis Pharmaceuticals UK Limited Europe
Upperton Limited Europe

Recent Private Companies Transactions

Type
Date		 Target
No transactions available in the past 12 months.
Report Data IssueReport Data Issue
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Celentyx Ltd., please visit www.celentyx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.

Close